Healthpeak Properties Inc. (NYSE:PEAK) went up by 3.03% from its latest closing price compared to the recent 1-year high of $35.79. The company’s stock price has collected 4.41% of gains in the last five trading sessions. Press Release reported on 07/16/21 that Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
Is It Worth Investing in Healthpeak Properties Inc. (NYSE :PEAK) Right Now?
Healthpeak Properties Inc. (NYSE:PEAK) scored a price-to-earnings ratio above its average ratio, recording 70.04 x from its present earnings ratio. Plus, the 36-month beta value for PEAK is at 0.68. Opinions of the stock are interesting as 8 analysts out of 20 who provided ratings for Healthpeak Properties Inc. declared the stock was a “buy,” while 3 rated the stock as “overweight,” 8 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $35.75, which is -$0.87 below the current price. PEAK currently public float of 537.80M and currently shorts hold a 1.26% ratio of that float. Today, the average trading volume of PEAK was 3.12M shares.
PEAK’s Market Performance
PEAK stocks went up by 4.41% for the week, with a monthly jump of 8.79% and a quarterly performance of 5.73%, while its annual performance rate touched 40.13%. The volatility ratio for the week stands at 2.08% while the volatility levels for the past 30 days are set at 1.85% for Healthpeak Properties Inc.. The simple moving average for the period of the last 20 days is 5.28% for PEAK stocks with a simple moving average of 15.32% for the last 200 days.
Analysts’ Opinion of PEAK
Many brokerage firms have already submitted their reports for PEAK stocks, with Mizuho repeating the rating for PEAK by listing it as a “Neutral.” The predicted price for PEAK in the upcoming period, according to Mizuho is $32 based on the research report published on July 14th of the current year 2021.
JP Morgan, on the other hand, stated in their research note that they expect to see PEAK reach a price target of $34. The rating they have provided for PEAK stocks is “Neutral” according to the report published on May 20th, 2021.
BofA Securities gave a rating of “Buy” to PEAK, setting the target price at $35.50 in the report published on March 30th of the current year.
PEAK Trading at 6.24% from the 50-Day Moving Average
After a stumble in the market that brought PEAK to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.59% of gains for the given period.
Volatility was left at 1.85%, however, over the last 30 days, the volatility rate increased by 2.08%, as shares surge +6.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.40% upper at present.
During the last 5 trading sessions, PEAK rose by +4.41%, which changed the moving average for the period of 200-days by +28.39% in comparison to the 20-day moving average, which settled at $34.30. In addition, Healthpeak Properties Inc. saw 19.09% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at PEAK starting from GARVEY CHRISTINE, who sale 889 shares at the price of $34.54 back on Jun 10. After this action, GARVEY CHRISTINE now owns 23,584 shares of Healthpeak Properties Inc., valued at $30,706 using the latest closing price.
GARVEY CHRISTINE, the Director of Healthpeak Properties Inc., sale 4,784 shares at $33.39 during a trade that took place back on May 06, which means that GARVEY CHRISTINE is holding 24,625 shares at $159,732 based on the most recent closing price.
Stock Fundamentals for PEAK
Current profitability levels for the company are sitting at:
- +23.65 for the present operating margin
- +19.75 for the gross margin
The net margin for Healthpeak Properties Inc. stands at +9.26. The total capital return value is set at 2.71, while invested capital returns managed to touch 1.11.
Based on Healthpeak Properties Inc. (PEAK), the company’s capital structure generated 95.43 points at debt to equity in total, while total debt to capital is 48.83. Total debt to assets is 40.69, with long-term debt to equity ratio resting at 93.16. Finally, the long-term debt to capital ratio is 47.67.
When we switch over and look at the enterprise to sales, we see a ratio of 14.81, with the company’s debt to enterprise value settled at 0.28. The receivables turnover for the company is 10.62 and the total asset turnover is 0.10.